Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol — Carly C. Barron (2017) | RDL Network
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol
Article 2017 en
Authors
CB
Carly C. Barron
ML
Manoj M. Lalu
DS
Duncan J. Stewart
Abstract
1 min read
This systematic review of preclinical evidence will provide a summary of the efficacy and safety of MSCs in animal models of MI. The results will help determine whether sufficient evidence exists to conduct a clinical trial in humans and inform its design.
Manoj M. Lalu, David Moher, John C. Marshall, Dean Fergusson, Shirley H. J. Mei, Malcolm Macleod, Gilly Griffin, Alexis F. Turgeon, Michael A. Rudnicki, Jason Fishman, Marc T. Avey, Becky Skidmore, Jeremy Grimshaw, Duncan J. Stewart, Kavita Singh, Lauralyn McIntyre
Lauralyn McIntyre, David Moher, Dean Fergusson, Katrina Sullivan, Shirley H. J. Mei, Manoj M. Lalu, John C. Marshall, Malcolm D. McLeod, Gilly Griffin, Jeremy Grimshaw, Alexis F. Turgeon, Marc T. Avey, Michael A. Rudnicki, M R Hadian Jazi, Jason Fishman, Duncan J. Stewart
Lauralyn McIntyre, Manoj M. Lalu, Katrina Sullivan, Shirley H. J. Mei, David Moher, Dean Fergusson, Alexander T. Strauss, Duncan J. Stewart, Mazen Jasi, Malcolm Macleod, Brent W. Winston, John Marshall, Keith R. Walley
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.